Abcellera Biologics Inc
ABCL3.720USD
+0.030+0.81%
Close 12/24, 13:00（ET）Quotes delayed by 15 min
1.11BMarket Cap
LossP/E TTM
Abcellera Biologics Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
28.83M
-24.17%
EPS(YoY)
-0.55
-9.29%
Analyst Rating
BUY
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Abcellera Biologics Inc?
According to Abcellera Biologics Inc's FY2024 earnings report, its total revenue reached 28.83M, with a year-on-year change of -24.17%.
What is the Earnings Per Share (EPS) of Abcellera Biologics Inc?
According to Abcellera Biologics Inc's FY2024 earnings report, its Earnings Per Share (EPS) was -0.553, with a year-on-year change of -9.29%.
What is the net income of Abcellera Biologics Inc?
According to Abcellera Biologics Inc's FY2024 earnings report, its net income was -162.86M, with a year-on-year change of -11.24%.
What is the net margin of Abcellera Biologics Inc?
According to Abcellera Biologics Inc's FY2024 earnings report, its net profit margin was -564.83%, with a year-on-year change of -46.71%.
What is the gross margin of Abcellera Biologics Inc?
According to Abcellera Biologics Inc's FY2024 earnings report, its gross margin was 100.00%, with a year-on-year change of --.
What is the debt-to-asset ratio of Abcellera Biologics Inc?
According to Abcellera Biologics Inc's FY2024 earnings report, its debt-to-asset ratio was --, with a year-on-year change of --.
What is the Return on Equity (ROE) of Abcellera Biologics Inc?
According to Abcellera Biologics Inc's FY2024 earnings report, its Return on Equity (ROE) was -14.75%, with a year-on-year change of -20.17%.
What is the Return on Assets (ROA) of Abcellera Biologics Inc?
According to Abcellera Biologics Inc's FY2024 earnings report, its Return on Assets (ROA) was -11.43%, with a year-on-year change of -18.29%.
What is the operating profit of Abcellera Biologics Inc?
According to Abcellera Biologics Inc's FY2024 earnings report, its operating profit was -250.77M, with a year-on-year change of -7.16%.
What are the current assets of Abcellera Biologics Inc?
According to Abcellera Biologics Inc's FY2024 earnings report, its current assets were 751.37M, with a year-on-year change of -13.83%.
What are the total assets of Abcellera Biologics Inc?
According to Abcellera Biologics Inc's FY2024 earnings report, its total assets of Abcellera Biologics Inc were 1.36B, with a year-on-year change of -8.57%.
What are the total liabilities of Abcellera Biologics Inc?
According to Abcellera Biologics Inc's FY2024 earnings report, its total liabilities of Abcellera Biologics Inc were 304.47M, with a year-on-year change of -9.32%.
What is the total equity of Abcellera Biologics Inc?
According to Abcellera Biologics Inc's FY2024 earnings report, its total equity of Abcellera Biologics Inc was 1.06B, with a year-on-year change of -8.35%.
What is the net operating income of Abcellera Biologics Inc?
According to Abcellera Biologics Inc's FY2024 earnings report, its net operating income of Abcellera Biologics Inc was -162.86M, with a year-on-year change of -11.24%.
What is the net investment of Abcellera Biologics Inc?
According to Abcellera Biologics Inc's FY2024 earnings report, its net investment of Abcellera Biologics Inc was 121.41M, with a year-on-year change of 154.91%.
What is the net financing of Abcellera Biologics Inc?
According to Abcellera Biologics Inc's FY2024 earnings report, its net financing of Abcellera Biologics Inc was 12.77M, with a year-on-year change of 23.30%.
